New aspects of natural-killer-cell surveillance and therapy of cancer

被引:595
作者
Smyth, MJ
Hayakawa, Y
Takeda, K
Yagita, H
机构
[1] Peter MacCallum Canc Inst, Div Res, Trescowthick Res Labs, Canc Immunol Lab, Melbourne, Vic 8006, Australia
[2] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
基金
英国医学研究理事会;
关键词
D O I
10.1038/nrc928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural-killer (NK) cells form a first line of defence against pathogens or host cells that are stressed and/or cancerous. NK cells express surface receptors that receive signals from the environment and determine their response to foreign or malignant cells. NK cells respond to these signals by producing effector molecules that can both directly suppress tumour growth and convey important information to the rest of the immune system. We have only recently begun to appreciate the potential for NK cells to be rationally manipulated in the treatment of human cancers.
引用
收藏
页码:850 / 861
页数:12
相关论文
共 163 条
[1]   Targeting death and decoy receptors of the tumour-necrosis factor superfamily [J].
Ashkenazi, A .
NATURE REVIEWS CANCER, 2002, 2 (06) :420-430
[2]  
Bakker ABH, 1998, J IMMUNOL, V160, P5239
[3]  
BARLOZZARI T, 1983, J IMMUNOL, V131, P1024
[4]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[5]  
BENYUNES MC, 1993, BONE MARROW TRANSPL, V12, P159
[6]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[7]   Activation and function of natural killer cell responses during viral infections [J].
Biron, CA .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :24-34
[8]   Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells [J].
Bradley, M ;
Zeytun, A ;
Rafi-Janajreh, A ;
Nagarkatti, PS ;
Nagarkatti, M .
BLOOD, 1998, 92 (11) :4248-4255
[9]  
Brandau S, 2000, CLIN CANCER RES, V6, P3729
[10]   Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer [J].
Burns, LJ ;
Weisdorf, DJ ;
DeFor, TE ;
Repka, TL ;
Ogle, KM ;
Hummer, C ;
Miller, JS .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) :96-103